Advertisements

Cadila Healthcare Q4 PAT seen up 39.7% YoY to Rs. 538.4 cr: Edelweiss

Cadila Healthcare Q4 PAT seen up 39.7% YoY to Rs. 538.4 cr: Edelweiss.....»»

Category: topSource: moneycontrolApr 16th, 2018

Cadila Healthcare launch pipeline points to healthy outlook, stock gains

Cadila Healthcare launch pipeline points to healthy outlook, stock gains.....»»

Category: featuresSource: business-standardMay 25th, 2018

Cadila Healthcare consolidated Q4 net up 53% to Rs 59 bn; income grows 27%

Cadila Healthcare consolidated Q4 net up 53% to Rs 59 bn; income grows 27%.....»»

Category: featuresSource: business-standardMay 25th, 2018

Cadila net rises 53.3% to ₹590.8 crore

Cadila net rises 53.3% to ₹590.8 crore.....»»

Category: topSource: the-hinduMay 25th, 2018

Cadila Healthcare gains 1% on USFDA final approval for Parkinson#39;s drug

Cadila Healthcare gains 1% on USFDA final approval for Parkinson#39;s drug.....»»

Category: topSource: moneycontrolMay 10th, 2018

Bullish on Cadila Healthcare, stock likely to test Rs 550 by FY19 end: Akash Jain

Bullish on Cadila Healthcare, stock likely to test Rs 550 by FY19 end: Akash Jain.....»»

Category: topSource: moneycontrolMay 7th, 2018

Cadila Healthcare up 3% on USFDA approval for Methylprednisolone, Cinacalcet Hydrochloride tablets

Cadila Healthcare up 3% on USFDA approval for Methylprednisolone, Cinacalcet Hydrochloride tablets.....»»

Category: topSource: moneycontrolApr 26th, 2018

Buy Cadila Healthcare, target Rs 450: Aditya Agarwal

Buy Cadila Healthcare, target Rs 450: Aditya Agarwal.....»»

Category: topSource: moneycontrolApr 25th, 2018

Cadila Healthcare Q4 PAT seen up 36.5% YoY to Rs. 530 cr: HDFC Securities

Cadila Healthcare Q4 PAT seen up 36.5% YoY to Rs. 530 cr: HDFC Securities.....»»

Category: topSource: moneycontrolApr 20th, 2018

Cadila Healthcare stock: Analysts see 20% compounded growth in US sales

Cadila Healthcare stock: Analysts see 20% compounded growth in US sales.....»»

Category: featuresSource: business-standardMar 30th, 2018

Top buzzing midcap stocks to trade on March 26

Top buzzing midcap stocks to trade on March 26.....»»

Category: topSource: moneycontrolMar 26th, 2018

Cadila Healthcare gains 4% on USFDA nod for Metoprolol Succinate tablets

Cadila Healthcare gains 4% on USFDA nod for Metoprolol Succinate tablets.....»»

Category: topSource: business-standardMar 26th, 2018

SBI, Tata Motors, Bosch among 60 stocks from BSE500 index hit 52-week lows

SBI, Tata Motors, Bosch among 60 stocks from BSE500 index hit 52-week lows.....»»

Category: topSource: business-standardMar 23rd, 2018

Cadila Healthcare up 2% on USFDA approval to market Tizanidine tablets

Cadila Healthcare up 2% on USFDA approval to market Tizanidine tablets.....»»

Category: topSource: moneycontrolMar 13th, 2018

Hold Cadila Healthcare, says Rajat Bose

Hold Cadila Healthcare, says Rajat Bose.....»»

Category: topSource: moneycontrolFeb 22nd, 2018

Stay with Cadila Healthcare: Vijay Chopra

Stay with Cadila Healthcare: Vijay Chopra.....»»

Category: topSource: moneycontrolFeb 22nd, 2018

Accumulate Cadila Healthcare; target of Rs 436: KR Choksey

Accumulate Cadila Healthcare; target of Rs 436: KR Choksey.....»»

Category: topSource: moneycontrolFeb 14th, 2018

Cadila Healthcare Q3 beats estimates, profit grows 68% despite significant rise in tax cost - Moneycontrol.com

Cadila Healthcare Q3 beats estimates, profit grows 68% despite significant rise in tax cost - Moneycontrol.com.....»»

Category: topSource: googlenewsFeb 8th, 2018

Cadila Healthcare Q3 beats estimates, profit grows 68% despite significant rise in tax cost

Cadila Healthcare Q3 beats estimates, profit grows 68% despite significant rise in tax cost.....»»

Category: topSource: moneycontrolFeb 8th, 2018

ABB, ACC, BHEL, SAIL results on Thursday

ABB, ACC, BHEL, SAIL results on Thursday.....»»

Category: marketsSource: thehindubusinesslineFeb 7th, 2018

Cadila Healthcare turns focus on vaccines and biosimilars

Cadila Healthcare turns focus on vaccines and biosimilars.....»»

Category: featuresSource: business-standardJan 24th, 2018